Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. - Wikidata - awgldk - TriplyDB

Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.

Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.

http://www.wikidata.org/entity/Q34149348

about

Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial.Response letter regarding the letter to the editors by Brown et al.

P2860

Q34199560-02ABBBB2-1ECA-47D4-A181-66CF51CF22B3 Q37135422-566806DE-0369-48AE-998C-04AD96E91497

P2860

Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.

http://www.wikidata.org/entity/Q34149348

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effect of different human papi ...... on vaccine efficacy estimates.

@ast

Effect of different human papi ...... on vaccine efficacy estimates.

@en

Effect of different human papi ...... on vaccine efficacy estimates.

@nl

type

label

Effect of different human papi ...... on vaccine efficacy estimates.

@ast

Effect of different human papi ...... on vaccine efficacy estimates.

@en

Effect of different human papi ...... on vaccine efficacy estimates.

@nl

prefLabel

Effect of different human papi ...... on vaccine efficacy estimates.

@ast

Effect of different human papi ...... on vaccine efficacy estimates.

@en

Effect of different human papi ...... on vaccine efficacy estimates.

@nl

P1433

Q34149348-5E07AF50-68DC-47AD-82F3-B4D2EFBB4DCE

P1476

Q34149348-BD6B18D9-C466-422B-96C3-65526EDFDAB2

P2093

Q34149348-0B640726-E05A-488A-A62C-857BC9572FEA

Q34149348-21C9551A-D5F8-4E00-939A-5EE8FBEC7291

Q34149348-368FBF39-24E4-4896-BADF-E3B2C1DB0CA2

Q34149348-47BC9BE2-D663-4AEA-8805-E2A7089925E8

Q34149348-4C59C2BD-1004-4477-BB32-96749B96A061

Q34149348-5204D30D-FE5D-4045-830C-6ADAC85CDAF5

Q34149348-57E08DC8-5A58-40E9-929F-7D705A994447

Q34149348-5A7537C1-86B0-4894-B862-4874BA15A50F

Q34149348-8D4609C5-F8FB-40EE-9286-D609C06D687F

Q34149348-9E966E84-D589-4F1C-B08B-881F34EAB873

P2860

Q34149348-001C3E0B-F3C4-46DC-B007-B00FA917F55C

Q34149348-00D80113-9491-4953-9DE7-16DCA4F52EDB

Q34149348-02B03C99-07AE-4729-AEDF-CEF7A0BDE9F2

Q34149348-322791CC-C82F-4D8E-91FE-F5E622A96BCC

Q34149348-338AA48E-4778-4CD0-BE03-2D96336BDE43

Q34149348-3D57C2C2-552B-4BE8-BDBB-6ECACDE0C136

Q34149348-4E302CC6-B10B-4A39-8C69-73E402259855

Q34149348-53902419-2BD0-440F-B2B8-73F8C22E1DDC

Q34149348-62C6038F-9080-421F-B95E-ED28641ABF2F

Q34149348-7AA6A7E6-A7CB-4307-8179-BB18754C06B7

P304

Q34149348-87FD512F-56F8-4361-93B2-C56BFE5E7241

P31

Q34149348-5D17D076-8D95-4939-AAB3-D5B6D855867B

P356

Q34149348-EF33ACF0-9B17-4F00-AB1B-A635B7CEFBF7

P407

Q34149348-6FE576AA-4968-4FD9-A13C-2CD4D2B18F44

P433

Q34149348-E3C5608A-22CF-47D0-8827-535FCC361415

P478

Q34149348-86203944-A729-4AB1-A6AD-1EF50DA22EB2

P50

Q34149348-0A7FC56D-E373-457E-8DE2-344776610730

Q34149348-5F9F8988-B4A3-4743-8E1E-A481BEBBC053

Q34149348-815BA36C-3197-466E-B7DB-7BACD8BC27CC

Q34149348-AD48734F-3885-4E5C-861B-98DC72EC0939

Q34149348-C9E1A9F9-3120-4FC9-A1AB-7B4EC3AD059D

Q34149348-D7B88037-51B8-43EE-96AB-DF5330D7FA06

P577

Q34149348-21B1EEEC-6768-4E67-9B74-2E5018848DA4

P5875

Q34149348-9539798C-C130-43FB-B797-81B3257BD60D

P698

Q34149348-846B0673-C23B-40F4-AA6E-E2FF86490635

P932

Q34149348-72035188-DA8F-43C6-9582-84A402E87EB8

P356

P1433

American Journal of Epidemiology

P1476

Effect of different human papi ...... on vaccine efficacy estimates.

@en

P2093

Aimée R Kreimer

http://www.w3.org/2001/XMLSchema#string

Arpita Ghosh

http://www.w3.org/2001/XMLSchema#string

Carolina Porras

http://www.w3.org/2001/XMLSchema#string

Costa Rica Vaccine Trial Group

http://www.w3.org/2001/XMLSchema#string

Douglas R Lowy

http://www.w3.org/2001/XMLSchema#string

John Schussler

http://www.w3.org/2001/XMLSchema#string

John T Schiller

http://www.w3.org/2001/XMLSchema#string

Krystle A Lang Kuhs

http://www.w3.org/2001/XMLSchema#string

Mark E Sherman

http://www.w3.org/2001/XMLSchema#string

Mary Sidawy

http://www.w3.org/2001/XMLSchema#string

P2860

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.

Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years.

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica

A review of clinical trials of human papillomavirus prophylactic vaccines.

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.

P304

599-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJE/KWU168

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

Sholom Wacholder

Allan Hildesheim

Ana Cecilia Rodríguez

Leen-Jan van Doorn

Mahboobeh Safaeian

P577

2014-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264941851

http://www.w3.org/2001/XMLSchema#string

P698

25139208

http://www.w3.org/2001/XMLSchema#string

P932

4157699

http://www.w3.org/2001/XMLSchema#string